Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-5866
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Arbitrary Directory Listing in Centrify PAS
Source: NVD (National Vulnerability Database)
Vulnerability Description
Vulnerability in Delinea Centrify PAS v. 21.3 and possibly others. The application is prone to the path traversal vulnerability allowing listing of arbitrary directory outside the root directory of the web application. Versions 23.1-HF7 and on have the patch.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
路径遍历:’dir/../filename’
Source: NVD (National Vulnerability Database)
Vulnerability Title
Delinea Centrify PAS 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Delinea Centrify PAS是美国Delinea公司的一个特权访问管理解决方案。 Delinea Centrify PAS v.21.3版本存在安全漏洞,该漏洞源于容易受到路径遍历漏洞的影响,允许列出应用程序根目录之外的任意目录。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
DelineaCentrify PAS v. 21.3 -
II. Public POCs for CVE-2024-5866
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-5866
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2024-5866

No comments yet


Leave a comment